Clinical Trial Update: Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM [NA]

View source ↗

Summary

This clinical trial update compares exenatide plus pioglitazone versus insulin in patients with poorly controlled type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Insulin (insulin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Dr. Muhammad Abdulghani | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN